Hyderabad-based Natco Pharma will acquire a 35.75% stake in Adcock Ingram Holdings Limited, South Africa, in a ₹1,970 crore cash deal.
Natco Pharma will acquire a 35.75% stake in Adcock Ingram Holdings Limited (AIHL), South Africa, for approximately Rs 1,970 crore in a cash deal.
The acquisition amounts to 51,643,319 equity shares, resulting in Hyderabad-based Natco’s shareholding reaching 35.75 per cent of the paid-up equity share capital of AIHL in aggregate, the company informed the BSE.
The nature of the acquisition is cash consideration at ZAR 75.00 per share, or ZAR 4 billion in aggregate, Natco informed the BSE. The transaction will be completed on or before December 31, 2025.
About AIHL
Founded in 1890 in South Africa, AIHL is a pharmaceutical company operating across four segments: prescription, consumer, OTC, and hospitals.
It has a diverse portfolio of products ranging from generic and branded formulations to critical-care hospital products, as well as consumer & home-care products.
According to Natco, the proposed acquisition is “a strategic investment with an objective of expanding geographic footprint in South Africa.’‘
Published on July 24, 2025